A partnership between Mitacs and Mental Health Research Canada is addressing the mental health challenges of Canadians, almost a quarter of whom report feeling anxious or depressed as a direct result of the COVID-19 pandemic.

When it comes to finding cures for rare diseases and addressing emerging viral infections — like COVID-19 — the traditional pharmaceutical business model just doesn’t cut it. Solutions require global collaboration and open-access research, and that means a new research innovation ecosystem — exactly what the Structural Genomics Consortium (SGC) is building.

Dr. Seyyedarash Haddadi developed a novel, low-cost compound — made from a graphene oxide-silver combination — that can be used as part of a coating material for masks; this material makes them 99.99 percent effective against transmission of COVID-19.

A Mitacs Globalink Research Award researcher from U of T wins Mitacs Award for original research on the Bohemian court and monarchy, illuminating the important role of medieval queens and their often overlooked yet significant contributions to politics and culture.

Small business entrepreneur and postdoctoral fellow at University of Waterloo uses machine learning to develop first-of-its-kind technology that has the potential to fight aquaculture’s problem with harmful algae blooms, which injure fish.

A Mitacs Globalink research intern from Germany works with the University of Waterloo’s Institute for Quantum Computing to investigate how to control quantum systems that have multiple states, and to understand the impact for real-life solutions.

A Mitacs Globalink research intern from Harvard University works with a Queen’s University lab to design an innovative device for rapid screening of pathogens that can cause Lyme disease as Ontario’s deer tick problem grows.

For several start-ups that are resident at JLABS @ Toronto, not even COVID-19 has paused their plans to recruit talent and scale up; they counted on Mitacs’s programs to help set their businesses up for potential success.

As cancer remains one of the leading causes of mortality worldwide, CanPRIME may prove to be a gift to many. The unique training program bolsters Canada’s capacity to manufacture COVID-19 vaccines, as well as viral immunotherapies for cancer.

A collaborative project supported by Mitacs utilizes research and industry expertise to produce faster and higher volume of manufacturing solutions for PPE and other products that address transmission of COVID-19.

A Globalink Research Internship leads to graduate studies in Canada for the founder of NuPort Robotics, the country’s first autonomous trucking company that uses eco-friendly, self-driving electric trucks for short-haul drives.

Research team from the University of Guelph is helping an Ontario-based company to provide a health care solution, innovate, and diversify their business by turning UV technology for cleaning fresh produce into a mask decontaminant.